Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy

This study has been completed.
Information provided by (Responsible Party):
Michael D. Sussman, MD, Shriners Hospitals for Children Identifier:
First received: April 5, 2006
Last updated: May 18, 2015
Last verified: May 2015